SCHEMBL29370260

SCHEMBL29370260

C=C1CCc2ccccc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 1/20 0.54
MAOB P27338 2/20 0.43
CYP2A6 P11509 1/20 0.43
MAOA P21397 1/20 0.43
SETD7 Q8WTS6 1/20 0.42
NOS3 P29474 1/20 0.40
NOS2 P35228 1/20 0.40
PDPK1 O15530 1/20 0.40
PARP1 P09874 1/20 0.40
PARP10 Q53GL7 1/20 0.40
PARP11 Q9NR21 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
SRD5A1 P18405 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
SRD5A2 P31213 1/20 0.39
TSHR P16473 1/20 0.39
NOTUM Q6P988 1/20 0.39
HPGD P15428 1/20 0.39
CYP19A1 P11511 2/20 0.38
CYP11B2 P19099 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL66102 1.00 CES1 (0.54) CES1MAOBCYP2A6MAOASETD7
SCHEMBL29795286 0.85 CYP2A6 (0.56) CES1MAOBCYP2A6MAOANOS3
SCHEMBL29795287 0.85 CYP2A6 (0.56) CES1MAOBCYP2A6MAOANOS3
SCHEMBL6691916 0.85 TSHR (0.55) CES1MAOBCYP2A6MAOANOS3
SCHEMBL11327557 0.85 CES1 (0.50) CES1MAOBCYP2A6MAOASETD7
SCHEMBL1822219 0.85 CYP2A6 (0.56) CES1MAOBCYP2A6MAOANOS3
SCHEMBL6006940 0.83 MEN1 (0.39) CES1MAOBCYP2A6MAOASETD7
SCHEMBL1739155 0.81 CES1 (0.71) CES1MAOBCYP2A6MAOAPDPK1
SCHEMBL30303760 0.81 CES1 (0.71) CES1MAOBCYP2A6MAOAPDPK1
SCHEMBL4039247 0.81 CES1 (0.56) CES1MAOBCYP2A6MAOASETD7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120041846-A Method for preparing indane compound under electrochemical condition 广东工业大学 2025-05-27 CN disclosed
US-20250002448-A1 ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS MERCK SHARP & DOHME LLC (US) 2025-01-02 US disclosed
CN-118159548-A Antiviral compounds 安力高医药股份有限公司 2024-06-07 CN disclosed
CN-117843537-A Method for preparing beta-amino sulfide by visible light catalysis 河南师范大学 2024-04-09 CN disclosed
EP-3944739-A2 METHODS OF CARBON-CARBON BOND FRAGMENTATION The Regents of the University of California (US) 2022-02-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250002448-A1 ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS CHRNA7, CHRM1, CHRM5 CES1 1780/4885MAOB 276/4885CYP2A6 1404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.